PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer. Zhang H, Zhang L, He Y, Jiang D, et al. Cancer Lett 2024 Jul 8:217112. doi: 10.1016/j.canlet.2024.217112.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang H, Zhang L, He Y, Jiang D, et al. PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer. Cancer Lett 2024 Jul 8:217112. doi: 10.1016/j.canlet.2024.217112.
PMID: 38986734